Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0ILL stock hub

LON/0ILL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0ILLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0ILL

In the news

Latest news · LON/0ILL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.4

P25 12.9P50 16.9P75 23.5

Trailing P/E24.1

P25 15.9P50 22.9P75 35.8

ROE20.5

P25 -54.2P50 2.1P75 13.7

ROIC17.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0ILL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

EUR

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	UK
Employees	1,998
Employees Change	51%
Employees Change Percent	2.56
Enterprise value	EUR 2.8B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	ES0157261019
Last refreshed	2026-05-10
Market cap	EUR 2.8B
Price	EUR 63
Price currency	EUR
Rev Per Employee	323,872.46x
Sector	Healthcare
Sic	2834
Symbol	lon/0ILL
Website	https://www.rovi.es

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.15%
EV Earnings	24.35x
EV/EBIT	20.24x
EV/EBITDA	17.67x
EV/FCF	27.54x
EV/Sales	4.38x
FCF yield	3.66%
Forward P/E	21.43x
P/B ratio	4.63x
P/E ratio	24.13x
P/S ratio	4.29x
PE Ratio10 Y	30.61x
PE Ratio3 Y	22.56x
PE Ratio5 Y	21.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.61%
EBITDA Margin	24.75%
FCF margin	15.73%
Gross margin	63.97%
Gross Profit	EUR 414M
Gross Profit Growth	0.35%
Gross Profit Growth Q	2.75%
Gross Profit Growth3 Y	-2.64%
Gross Profit Growth5 Y	13.47%
Net Income	EUR 115.1M
Net Income Growth	-5.86%
Net Income Growth Q	-47.63%
Net Income Growth Years	1%
Net Income Growth3 Y	-12.1%
Net Income Growth5 Y	13.18%
Pretax Margin	23.3%
Profit Margin	17.79%
Profit Per Employee	EUR 57,609
Profitable Years	14
ROA	11.5
Roa5y	15.81
ROCE	20.57
ROE	20.48
Roe5y	31.03
ROIC	17.42
Roic5y	30.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.82%
Cagr15y	19.72%
Cagr1y	24.76%
Cagr3y	16.14%
Cagr5y	6.79%
Div CAGR10	21.48%
Div CAGR3	-9.96%
Div CAGR5	10.94%
EPS Growth Years	1
FCF Growth	39.98%
FCF Growth Q	-49.37%
FCF Growth3 Y	3.73%
FCF Growth5 Y	29.88%
OCF Growth	27.98%
OCF Growth Q	-31.23%
OCF Growth10 Y	16.31%
OCF Growth3 Y	4.67%
OCF Growth5 Y	20.37%
Revenue Growth	-3.44x
Revenue Growth Q	-1.55x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.07x
Revenue Growth5 Y	10.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.85
Assets	EUR 808.8M
Cash	EUR 85M
Current Assets	EUR 466.5M
Current Liabilities	EUR 127.6M
Debt	EUR 99.9M
Debt EBITDA	EUR 0.62
Debt Equity	EUR 0.17
Debt FCF	EUR 0.98
Equity	EUR 599.6M
Interest Coverage	58.95
Liabilities	EUR 209.2M
Long Term Assets	EUR 342.3M
Long Term Liabilities	EUR 81.6M
Net Cash	EUR -14.9M
Net Cash By Market Cap	EUR -0.54
Net Debt EBITDA	EUR 0.09
Net Debt Equity	EUR 0.02
Net Debt FCF	EUR 0.15
Tangible Book Value	EUR 557.8M
Tangible Book Value Per Share	EUR 10.9
WACC	5.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.66
Inventory Turnover	0.9
Net Working Capital	EUR 281.3M
Quick ratio	1.77
Working Capital	EUR 342.1M
Working Capital Turnover	EUR 1.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-12.84%
Dividend Growth Years	0%
Dividend per share	EUR 0.66
Dividend Years	18
Dividend Yield	1.05%
Ex Div Date	2025-07-14
Last Dividend	EUR 0.66
Payout Frequency	Annual
Payout Ratio	36.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	373.1%
1Y total return	24.74%
200-day SMA	66.92
3Y total return	56.68%
50-day SMA	80.48
50-day SMA vs 200-day SMA	50over200
5Y total return	38.85%
All Time High	93.9
All Time High Change	-32.91%
All Time High Date	2024-05-27
All Time Low	4.75
All Time Low Change	1,226.35%
All Time Low Date	2012-02-09
ATR	3.44
Beta	0.33
Ch YTD	-0.71
High	63.4
High52	87.5
High52 Date	2026-04-21
High52ch	-28%
Low	61.5
Low52	50
Low52 Date	2025-05-23
Low52ch	26%
Ma50ch	-21.72%
Price vs 200-day SMA	-5.86%
RSI	18.63
RSI Monthly	48.3
RSI Weekly	40.66
Sharpe ratio	0.6x
Sortino ratio	0.95
Total Return	1.05%
Tr YTD	-0.71
Tr15y	1,388.56%
Tr1m	-22.08%
Tr1w	-20.65%
Tr3m	-13.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 139.9M
Operating Income Growth	-12.22
Operating Income Growth Q	-56.75
Operating Income Growth3 Y	-13.35
Operating Income Growth5 Y	11.72
Operating margin	21.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,296,127%
Net Borrowing	-266,429.8
Shares Institutions	15.34%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 101.8M
Average Volume	41,754.4x
Bv Per Share	11.5
CAPEX	EUR -56.5M
Ch10y	328.5
Ch15y	1,135.3
Ch1m	-22.08
Ch1w	-20.65
Ch1y	23.06
Ch3m	-13.46
Ch3y	49.17
Ch5y	29.77
Ch6m	14.55
Change	0.48%
Change From Open	0
Close	62.7
Days Gap	0.47
Depreciation Amortization	20,136,207.6
Dollar Volume	731,261.7
Earnings Date	2026-05-06
EBIT	EUR 139.9M
EBITDA	EUR 160.2M
EPS	EUR 2.25
F Score	5
FCF	EUR 101.8M
FCF EV Yield	3.63x
Financing CF	-41,039,242
Fiscal Year End	December
Founded	1,946
Goodwill	2,337,315.6
Graham Number	28.27303
Graham Upside	-55.12
Income Tax	EUR 35.8M
Investing CF	-57,723,877
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Lynch Fair Value	EUR 34.42
Lynch Upside	-45.36
Ma150	70.12
Ma150ch	-10.16%
Ma20	79.99
Ma20ch	-21.24%
Net CF	59,450,145
Next Earnings Date	2026-07-23
Open	63
P FCF Ratio	27.29
P OCF Ratio	17.55
Payment Date	2025-07-16
Position In Range	79.04
Ppne	284,817,738.4
Price Date	2026-05-08
Price EBITDA	EUR 17.34
Ptbv Ratio	4.98
Relative Volume	0.28x
Revenue	647,097,171x
Tax By Revenue	5.53x
Tax Rate	23.72%
Tr6m	14.55%
Volume	11,607

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0ILL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$0.66 annual per share

Payout ratio

+36.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.9%

0 consecutive years of growth

Total shareholder yield

+1.0%

Next ex-dividend date: 2025-07-14

Performance

LON/0ILL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0ILL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0ILL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

18.6

Below 30: short-term oversold

Price vs 200-day MA

-5.9%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

0.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0ILL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0ILL stock rating?

lon/0ILL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0ILL analysis?

The full report lives at /stocks/lon/0ILL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0ILL?

The latest report frames lon/0ILL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0ILL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.